Donor Lymphocyte Infusion: Clinical Trials

3 trials for Donor Lymphocyte Infusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 2, Completed 1
Phase 31Completed 1

Follow Donor Lymphocyte Infusion: new trials by email Literature Review of Donor Lymphocyte Infusion trials Research Report on Donor Lymphocyte Infusion

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies
Prophylactic DLI - Donor Lymphocyte Infusion, Peripheral Blood Stem Cell Transplantation
Phase 2UnknownChinese PLA General Hospital402019-01-012018-12-13
Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant
donor lymphocyte infusion - Donor Lymphocyte Infusion, Allogeneic Hematopoietic Stem Cell Transplantation
Phase 2UnknownPeking University People's Hospital402017-03-012020-03-10
MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT
donor lymphocyte infusion - Minimal Residual Disease, Donor Lymphocyte Infusion
Phase 2 / Phase 3CompletedNanfang Hospital, Southern Medical University2062016-01-012020-02-25

Narrower conditions

Recurrence (3)  ·  Graft vs Host Disease (2)  ·  Neoplasm, Residual (2)

Broader conditions

Disease Attributes (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Immune System Diseases (2)  ·  Neoplasms (2)  ·  Neoplastic Processes (2)

Interventions

Decitabine (1)  ·  Drug Therapy (1)

Sponsors

Chinese PLA General Hospital (1)  ·  Nanfang Hospital, Southern Medical University (1)  ·  Peking University People's Hospital (1)

Countries

China (3)

Top investigators

Qifa Liu (1)  ·  Xiao-jun Huang (1)

Results publications

PMID 32164760, PMID 35467818